The development of new and effective antibacterial drugs to treat multi-drug resistant (MDR)
bacteria, especially Gram-negative (G− ve) pathogens, is acknowledged as one of the …

Successful treatment of tuberculosis (TB) can be hampered by Mycobacterium tuberculosis
populations that are temporarily able to survive antibiotic pressure in the absence of drug …

Tuberculosis (TB) is currently the second deadliest infectious disease. Existing
antitubercular therapies are long, complex, and have severe side effects that result in low …

Combination therapies can overcome antimicrobial resistance (AMR) and repurpose
existing drugs. However, the large combinatorial space to explore presents a daunting …

Tuberculosis (TB) is one of the most threatening diseases for humans, however, the drug
treatment strategy for TB has been stagnant and inadequate, which could not meet current …

Mycobacterium abscessus (Mab), an emerging opportunistic pathogen, predominantly
infects individuals with underlying pulmonary diseases such as cystic fibrosis (CF). Current …

Central nervous system disorders are expected to profoundly impact the global healthcare
needs of the human community in this era. Senile decay of neurons is (Alzheimers Disease) …

Novel anti-tuberculosis drugs are essential to manage drug-resistant tuberculosis, caused
by Mycobacterium tuberculosis. We recently reported the antimycobacterial activity of …

Tuberculosis (TB) is the deadliest infectious disease worldwide. The design of new
treatments for TB is hindered by the large number of candidate drugs, drug combinations …

Essential oils of Citrus sinensis and Citrus latifolia have shown biological functions as
antiseptics, anti-inflammatories, antioxidants, antifungal and antimutagenic, so the …